- Official Masters eCampus
- eCampus Masters, Postgraduates and Courses
- Timetables and calendars
- Future Students
- Contact information
- About the TecnoCampus Park
- TecnoCampus Facilities
- HUB4T TecnoCampus
- Alumni
- TecnoCampus University Center
- Teaching staff
- Service for Quality and Teaching Innovation
- Library -CRAI
- Host your company
- Communication and press room
- TecnoCampus corporate image
- Events
- Transparency portal
- Equality Unit
- Supplier's Office
- Work with us
- TecnoCampus quality
What are you looking for?
Banting Labs, based at the TecnoCampus in Mataró, has secured an investment of 70.000 euros to advance its blood glucose monitoring technology. They develop an integrated multisensor that offers continuous and real-time readings of glucose levels, without being invasive.
This funding will allow to continue with the development of the prototype and the management of the intellectual property. The company hopes to bring the product to market in 2027 to improve the quality of life for people with diabetes. The idea came from the personal experience of the CEO, whose family member was diagnosed with type 1 diabetes. The device promises to provide accurate and real-time readings, reducing the risk of hypoglycemia and improving glycemic stability for patients. The company is preparing for the first clinical trial to validate the prototype of the device.
Institution
Study
Become an entrepreneur
TecnoCampus Park Mataró-Maresme
Tel. +34 93 169 65 00
info@tecnocampus.cat
Av. Ernest Lluch, 32 | 08302 Mataró
© 2024 TecnoCampus. All rights reserved.
Web project developed by ACTIUM Digital